Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading
| Autor: | Michael S. Radin |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
American diabetes association
Blood Glucose Glycated Hemoglobin medicine.medical_specialty endocrine system diseases business.industry nutritional and metabolic diseases Review Article Patient-centered care Hemoglobin A1c measurement medicine.disease Surgery Diabetes Mellitus Type 2 Diabetes mellitus Internal Medicine medicine Humans In patient Female Intensive care medicine business Glycemic |
| Popis: | Since the beginning of clinical use in the 1970s, hemoglobin A1c (A1c) has become the standard tool for monitoring glycemic control in patients with diabetes. The role of the A1c test was broadened in 2010, when the American Diabetes Association added A1c as a diagnostic criterion for diabetes. Because of hemoglobin A1c’s integral role in diagnosis and treatment, it is important to recognize clinical scenarios and interfering factors that yield false results. The purpose of this review is to describe the A1c measurement, outline clinical scenarios or factors that may yield false results, and describe alternative laboratory biomarkers. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|